Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 26: 770-771, 1980;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissman, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weissman, E. B.

Clinical Chemistry, Vol 26, 770-771, Copyright © 1980 by American Association for Clinical Chemistry

Carcinoembryonic antigen assayed by column chromatography on polyacrylamide gel

EB Weissman

I evaluated a commercially available polyacrylamide column (Clinetics Corp.) for use in assaying for carcinoembryonic antigen. The procedure eliminates the need for dialysis and 50 samples, assayed in duplicate, may be completed in 5 h. In general, results by this technique are 1.0 microgram/L (range 0.5-2.0) lower than by the conventional dialysis method (r = 0.9876). Sensitivity approximates 0.5 microgram/L. Within- day precision for two pools of patients' plasma (n = 10) was mean = 2.29 (SEM 0.05) microgram/L with CV = 6.55% and mean = 10.61 (SEM 0.10) microgram/L with CV = 2.92%, respectively; between-day precision (n = 6) was mean = 3.90 (SEM 0.16) microgram/L with CV = 10.0% and mean = 10.1 (SEM 0.37) microgram/L, CV = 8.91%, respectively. The precentage analytical recovery of added carcinoembryonic antigen was about 80% at concentrations of approximately 8 and 12 microgram/L, 73% at 18 microgram/L.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Association for Clinical Chemistry.